The use of amikacin liposome inhalation suspension (Arikayce) in the treatment of refractory nontuberculous mycobacterial lung disease in adults O Khan, N Chaudary Drug design, development and therapy, 2287-2294, 2020 | 59 | 2020 |
Beta-blockers in the prevention and treatment of ischemic heart disease: evidence and clinical practice O Khan, M Patel, AN Tomdio, J Beall, IS Jovin Heart Views 24 (1), 41-49, 2023 | 10 | 2023 |
Phosphodiesterase 5 Inhibitors and the Risk of Nephropathy and Long-Term Outcomes After Coronary Angiography and Percutaneous Coronary Intervention S Roy, A Min, O Khan, R Perera, IS Jovin Cardiovascular Revascularization Medicine 40, 79, 2022 | | 2022 |
Intracoronary thrombus visualized by optical coherence tomography in a patient with antiphospholipid syndrome R Choxi, M Kabach, DB Patel, O Khan, N Abouzaki, IS Jovin Imaging, 2022 | | 2022 |
CRT-500.08 Phosphodiesterase 5 Inhibitors and the Risk of Nephropathy and Long-Term Outcomes After Coronary Angiography and Percutaneous Coronary Intervention S Roy, A Min, O Khan, R Perera, IS Jovin Cardiovascular Interventions 15 (4_Supplement), S47-S47, 2022 | | 2022 |